BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3787183)

  • 1. Cytochrome b and FAD content in polymorphonuclear leucocytes in a family with X-linked chronic granulomatous disease.
    Riccardi S; Giordano D; Schettini F; De Mattia D; Lovecchio T; Santoro N; Fumarulo R
    Scand J Haematol; 1986 Oct; 37(4):333-6. PubMed ID: 3787183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reevaluation of cytochrome b and flavin adenine dinucleotide in neutrophils from patients with chronic granulomatous disease and description of a family with probable autosomal recessive inheritance of cytochrome b deficiency.
    Ohno Y; Buescher ES; Roberts R; Metcalf JA; Gallin JI
    Blood; 1986 Apr; 67(4):1132-8. PubMed ID: 3955232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of 25 patients with chronic granulomatous disease: a new classification by correlating respiratory burst, cytochrome b, and flavoprotein.
    Bohler MC; Seger RA; Mouy R; Vilmer E; Fischer A; Griscelli C
    J Clin Immunol; 1986 Mar; 6(2):136-45. PubMed ID: 3011845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular localization of the human neutrophil NADPH oxidase. b-Cytochrome and associated flavoprotein.
    Borregaard N; Tauber AI
    J Biol Chem; 1984 Jan; 259(1):47-52. PubMed ID: 6706948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular heterogeneity in chronic granulomatous disease: a human model of defective phagocyte superoxide production.
    Gabig TG; Lefker BA
    J Free Radic Biol Med; 1985; 1(1):65-9. PubMed ID: 3013973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome b-245 is a flavocytochrome containing FAD and the NADPH-binding site of the microbicidal oxidase of phagocytes.
    Segal AW; West I; Wientjes F; Nugent JH; Chavan AJ; Haley B; Garcia RC; Rosen H; Scrace G
    Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):781-8. PubMed ID: 1320378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of FAD with the cytochrome b-245 of human neutrophils.
    Cross AR; Jones OT; Garcia R; Segal AW
    Biochem J; 1982 Dec; 208(3):759-63. PubMed ID: 7165731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NADPH-binding component of the superoxide-generating oxidase in unstimulated neutrophils and the neutrophils from the patients with chronic granulomatous disease.
    Umei T; Takeshige K; Minakami S
    Biochem J; 1987 Apr; 243(2):467-72. PubMed ID: 3632631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new X-linked variant of chronic granulomatous disease characterized by the existence of a normal clone of respiratory burst-competent phagocytic cells.
    Woodman RC; Newburger PE; Anklesaria P; Erickson RW; Rae J; Cohen MS; Curnutte JT
    Blood; 1995 Jan; 85(1):231-41. PubMed ID: 7803797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic granulomatous disease in an adult female with granulomatous cheilitis. Evidence for an X-linked pattern of inheritance with extreme lyonization.
    Dusi S; Poli G; Berton G; Catalano P; Fornasa CV; Peserico A
    Acta Haematol; 1990; 84(1):49-56. PubMed ID: 2117330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A variant form of X-linked chronic granulomatous disease with normal nitroblue tetrazolium slide test and cytochrome b.
    Borregaard N; Cross AR; Herlin T; Jones OT; Segal AW; Valerius NH
    Eur J Clin Invest; 1983 Jun; 13(3):243-8. PubMed ID: 6409648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staining of eosinophils with nitroblue tetrazolium in patients with chronic granulomatous disease.
    Roberts RL; Ohno Y; Gallin JI
    Pediatr Res; 1986 Apr; 20(4):378-80. PubMed ID: 2422626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The superoxide-generating oxidase of leucocytes. NADPH-dependent reduction of flavin and cytochrome b in solubilized preparations.
    Cross AR; Parkinson JF; Jones OT
    Biochem J; 1984 Oct; 223(2):337-44. PubMed ID: 6497852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of the solubilized NADPH:O2 oxidoreductase of human neutrophils. Isolation of its catalytically inactive cytochrome b and flavoprotein redox centers.
    Green TR; Pratt KL
    J Biol Chem; 1988 Apr; 263(12):5617-23. PubMed ID: 3356702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease.
    Dinauer MC; Pierce EA; Erickson RW; Muhlebach TJ; Messner H; Orkin SH; Seger RA; Curnutte JT
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11231-5. PubMed ID: 1763037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the electron-transfer mechanism of the human neutrophil NADPH oxidase.
    Ellis JA; Cross AR; Jones OT
    Biochem J; 1989 Sep; 262(2):575-9. PubMed ID: 2553003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient flavoprotein component of the NADPH-dependent O2-.-generating oxidase in the neutrophils from three male patients with chronic granulomatous disease.
    Gabig TG; Lefker BA
    J Clin Invest; 1984 Mar; 73(3):701-5. PubMed ID: 6707199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked chronic granulomatous disease: correction of NADPH oxidase defect by retrovirus-mediated expression of gp91-phox.
    Porter CD; Parkar MH; Levinsky RJ; Collins MK; Kinnon C
    Blood; 1993 Oct; 82(7):2196-202. PubMed ID: 8400270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of pyridine nucleotide oxidizing enzymes from human neutrophils.
    Mackler B; Person R; Davis KA; Ochs H
    Biochem Int; 1985 Sep; 11(3):319-25. PubMed ID: 3933511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity.
    Woodman RC; Erickson RW; Rae J; Jaffe HS; Curnutte JT
    Blood; 1992 Mar; 79(6):1558-62. PubMed ID: 1312372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.